Phase 2 Blasts More Than 5 Percent of Bone Marrow Nucleated Cells Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

Refractory Acute Myeloid LeukemiaBlasts More Than 5 Percent of Bone Marrow Nucleated CellsPersistent Disease

Ohio State University Comprehensive Cancer Center28 enrolled2 locationsNCT04049539

Recruiting

Phase 2

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

Blasts More Than 5 Percent of Bone Marrow Nucleated CellsBCR-JAK2 Fusion Protein ExpressionBlasts 20 Percent or Less of Peripheral Blood White Cells+2 more

William Shomali10 enrolled4 locationsNCT03801434